NBIX

-3.2%🟢 Fundamentally supported

Neurocrine Biosciences Inc · Healthcare

$136.88Vol 490.0K · 0.8× normalMkt cap −$0.46Blive · 2026-10-13 ET

What happened

Move

-3.2%

Price

$136.88

Volume

490.0K

0.8× normal

Market cap

$13.91B

−$0.46B today

Why it moved

Analyst downgrademedium confidence

BMO Capital Maintains Market Perform on Neurocrine Biosciences, Lowers Price Target to $150 — finnhub-news

Possible catalyst: analyst downgrade, 2.6pp below its sector.

Verdict — was the move justified?

🟢 Fundamentally supported

Analyst downgrade — direction and rough magnitude are consistent with the identified fundamental catalyst.

How unusual is this move

σ score

1.9σ

vs own 20d volatility

Percentile

92th

of 1265 daily moves

Avg daily move

±1.4%

own 5y average

vs sector

-2.6%

beyond sector median

Today’s move is among the largest 8% of NBIX’s daily moves over the last 5 years — while the sector moved -0.6% and the market -0.3%.

What happened after similar moves

95 similar down moves in NBIX’s 5-year history:

After 5 days

+0.9%

55% higher

After 20 days

+1.6%

65% higher

Median of same-direction moves within ±35% magnitude band. Past patterns don’t predict outcomes — context, not signal.

Fundamental context

V 77G 100P 85H 88Q 67

Insider activity (90d): net selling $493.3K

Valuation context

P/E (TTM)

20.4

5y median 39.2

P/E percentile

vs own 5y history

FCF yield

0.1%

Trading cheaper than 91% of its own historical valuation range.

Full fundamental analysis on PreMarketPrice

Pillar scores, financial statements, valuation history, news & more for NBIX

→